# E119: Teclistamab for Rheumatology Writ Large

Page: https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e119-teclistamab-for-rheumatology-writ-large
Text version: https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e119-teclistamab-for-rheumatology-writ-large.md
Podcast: [The Evidence Based Rheumatology Podcast](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175)
Published: 2025-02-10T16:55:00+00:00
Episode link: https://msputman.podbean.com/e/e119-teclistamab-for-rheumatology-writ-large/
Audio file: https://mcdn.podbean.com/mf/web/hnxheudkwe8dnbc7/e119.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e119-teclistamab-for-rheumatology-writ-large
Duration seconds: 652

## Resource

One of my rare case-report podcasts, a topic that I typically avoid. The craze about CAR-T has also made me a little crazy, though, so I wanted to share what I think may be the ultimate destination for "more B cell depletion than rituximab" strategies. Article: https://www.nejm.org/doi/full/10.1056/NEJMc2407150

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e119-teclistamab-for-rheumatology-writ-large/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e119-teclistamab-for-rheumatology-writ-large.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.